Oncological Interventional Radiology in liver metastases

被引：0

作者：

Enrique Rojas-Marin, Carlos ^{[1
]}

Alejandra Lara, Eunice ^{[1
]}

Sebastian-Huerta, Janin ^{[2
]}

Ramirez, Esteban ^{[2
]}

Guerrero, Jorge ^{[3
]}

Jose Gonzalez-Aguirre, Adrian ^{[4
]}

机构：

[1] Inst Nacl Cancerol, Serv Radiol Intervencionista, Mexico City, DF, Mexico

[2] Inst Nacl Cancerol, Residencia Radiol Intervencionista, Mexico City, DF, Mexico

[3] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Residencia Radiol Intervencionista, Mexico City, DF, Mexico

[4] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Div Radiol Intervencionista, Mexico City, DF, Mexico

来源：

GACETA MEXICANA DE ONCOLOGIA | 2013年 / 12卷 / 05期

关键词：

Liver metastasis; Percutaneous ablation; Chemoembolization Radioembolization and portal vein embolization; Mexico;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Hepatic metastatic disease is the most common cause of death in cancer patients. Complete surgical resection is currently considered curative treatment, however only 25% of patients are candidates at the time of diagnosis. Show the different techniques oncologic interventional radiology has been developed for the treatment of hepatic metastases. The purpose of these procedures is to allow patients options curative or palliative treatment and those who are not candidates for surgery, making them candidates for surgery and even improve survival. Among the most commonly performed procedures are: percutaneous ablation, intra-arterial chemoembolization, radioembolization and embolization of the portal vein. This review describes the indications and techniques for implementing those procedures.

引用

页码：344 / 353

页数：10

共 45 条

[1] A comparison of percutaneous cryosurgery and percutaneous radiofrequency for unresectable hepatic malignancies
Adam, R
Hagopian, EJ
Linhares, M
Krissat, J
Savier, E
Azoulay, D
Kunstlinger, F
Castaing, D
Bismuth, H
[J]. ARCHIVES OF SURGERY, 2002, 137 (12) : 1332 - 1339
[2] Principles of and Advances in Percutaneous Ablation
Ahmed, Muneeb
Brace, Christopher L.
Lee, Fred T., Jr.
Goldberg, S. Nahum
[J]. RADIOLOGY, 2011, 258 (02) : 351 - 369
[3] Aliberti C, 2011, ANTICANCER RES, V31, P4581
[4] Preoperative Liver Hypertrophy Induced by Portal Flow Occlusion Before Major Hepatic Resection for Colorectal Metastases Can Be Impaired by Bevacizumab
Aussilhou, Beatrice
Dokmak, Safi
Faivre, Sandrine
Paradis, Valerie
Vilgrain, Valerie
Belghiti, Jacques
[J]. ANNALS OF SURGICAL ONCOLOGY, 2009, 16 (06) : 1553 - 1559
[5] Radiofrequency and Microwave Ablation of the Liver, Lung, Kidney, and Bone: What Are the Differences?
Brace, Christopher L.
[J]. CURRENT PROBLEMS IN DIAGNOSTIC RADIOLOGY, 2009, 38 (03) : 135 - 143
[6] Tumour dosimetry in human liver following hepatic yttrium-90 microsphere therapy
Campbell, AM
Bailey, IH
Burton, MA
[J]. PHYSICS IN MEDICINE AND BIOLOGY, 2001, 46 (02) : 487 - 498
[7] Escalated focal liver radiation and concurrent hepatic artery fluorodeoxyuridine for unresectable intrahepatic malignancies
Dawson, LA
McGinn, CJ
Normolle, D
Ten Haken, RK
Walker, S
Ensminger, W
Lawrence, TS
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (11) : 2210 - 2218
[8] Predictive Factors for Hypertrophy of the Future Remnant Liver After Selective Portal Vein Embolization
de Baere, Thierry
Teriitehau, Christophe
Deschamps, Frederic
Catherine, Laurence
Rao, Pramod
Hakime, Antoine
Auperin, Anne
Goere, Diane
Elias, Dominique
Hechelhammer, Lukas
[J]. ANNALS OF SURGICAL ONCOLOGY, 2010, 17 (08) : 2081 - 2089
[9] Radio-frequency tissue ablation of the liver: in vivo and ex vivo experiments with four different systems
Denys, AL
De Baere, T
Kuoch, V
Dupas, B
Chevallier, P
Madoff, DC
Schnyder, P
Doenz, F
[J]. EUROPEAN RADIOLOGY, 2003, 13 (10) : 2346 - 2352
[10] Fiorentini G, 2012, ANTICANCER RES, V32, P1387

← 1 2 3 4 5 →